Meda AB
| OTCPK:MDABY | |
| Headquarters | Solna, Sweden |
| Revenue | >kr 15 billion (2014) |
|
Number of employees
|
5,202 (2014) |
Meda AB is an international specialty pharmaceutical company, headquartered in Solna, Sweden. Sales at the end of 2014 amounted to more than kr 15 billion, making it the 48th largest pharmaceutical company in the world. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are sold in more than 150 countries.[1]
Meda has been listed since 1995 on the Stockholm stock market and is currently part of the Nasdaq OMX Nordic 120 index, though not of the OMX Nordic 40.[2]
Mergers, acquisitions and divestments
In 2014, Meda acquired the Italian firm RottaPharm Madaus in order to add consumer health products to their portfolio.[3] Meda explored in 2015 the possibility of divesting its United States division, Meda Pharmaceuticals, to raise funds for expansion in other areas.[3]
| Meda |
|
|||||||||
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.[self-published source]
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 3.0 3.1 Lua error in package.lua at line 80: module 'strict' not found.
